Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 157Brain Neoplasms 98Glioma 69Gliosarcoma 43Astrocytoma 30Carcinoma, Non-Small-Cell Lung 19Recurrence 18Oligodendroglioma 18Central Nervous System Neoplasms 16Neoplasms 14Meningeal Carcinomatosis 10Ependymoma 10Meningioma 7Neurofibromatosis 2 6Neuroblastoma 6Melanoma 6Diffuse Intrinsic Pontine Glioma 6Neuroma, Acoustic 5Medulloblastoma 5Lung Neoplasms 5Carcinoma, Renal Cell 5Squamous Cell Carcinoma of Head and Neck 4Neurologic Manifestations 4Colorectal Neoplasms 4Breast Neoplasms 4Spinal Cord Neoplasms 3Salivary Gland Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3

Interventions

trametinib 2dabrafenib 2mirdametinib 1gallium Ga 68 dotatate 1Vincristine 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ga(III)-DOTATOC 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroma × Bevacizumab × CNS × Clear all
NCT01999270 2016-10-21

Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

Washington University School of Medicine

Phase 1 Completed
6 enrolled
CNS

Astrocytoma, Ganglioneuroma, Glioma, Ganglioglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡